We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Agronomics Limited | LSE:ANIC | London | Ordinary Share | IM00B6QH1J21 | ORD 0.0001P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.40 | 5.00% | 8.40 | 8.10 | 8.40 | 8.25 | 8.00 | 8.00 | 1,211,081 | 16:35:19 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Investors, Nec | 30.88M | 22.37M | 0.0222 | 3.72 | 83.28M |
TIDMANIC
RNS Number : 3695E
Agronomics Limited
27 October 2022
27 October 2022
Agronomics Limited
("Agronomics" or the "Company")
Director Dealings
Further to the announcement by the Company on 25 April 2022, Agronomics Limited (the "Company") has been notified by Shellbay Investments Limited ("Shellbay") that following expiry of the second vesting period certain of its management and advisory consultants ("Option Holders") have elected to exercise the nil paid options granted by Shellbay in relation to certain shares of the Company held by Shellbay ("Options"). In aggregate, Option Holders have exercised Options over 3,133,074 shares, and the transfer of these shares to relevant Option Holders shall occur with immediate effect. Included in these figures, Mr Denham Eke, a director of the Company, has exercised Options over 213,445 shares held by Shellbay.
Shellbay is a company indirectly wholly owned by Mr James Mellon, a Director of the Company. Mr Denham Eke is also a director of Shellbay.
Following the exercise of Options, Shellbay holds, in aggregate, 12,097,782 Ordinary Shares of the Company, of which 8,278,633 shares remain subject to the Options.
Following the exercise of Options, the interests of the Directors in Ordinary Shares is as set out below:
No. of Ordinary Shares % of current issued Ordinary Shares Jim Mellon* 145,677,122 14.90% ----------------------- ----------------------------------- Richard Reed** 6,354,412 0.65% ----------------------- ----------------------------------- David Giampaolo 2,434,783 0.25% ----------------------- ----------------------------------- Denham Eke 426,890 0.04% ----------------------- -----------------------------------
*Jim Mellon is currently interested in a total of 145,677,122 Ordinary Shares, of which 132,305,380 are held by Galloway Limited and 12,097,782 are held by Shellbay, companies which are both indirectly wholly owned by Jim Mellon, and 1,273,960 Ordinary Shares are held directly by Mr Mellon. Denham Eke is a director of Galloway Limited and Shellbay Investments Limited.
** Richard Reed is currently interested in 6,354,412 Ordinary Shares held by Reepa Limited. Reepa Limited is wholly owned by Richard Reed.
In addition, it is noted for information only that to satisfy current and future tax liabilities relating to the exercise of Options, an advisory company owned by Mr Anthony Chow, a consultant indirectly engaged by Shellbay, sold 3,124,540 Ordinary Shares at a price of 14 pence per share. Accordingly, Mr Chow retains 3,221,752 Ordinary Shares and 6,250,902 Options.
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF THE MARKET ABUSE REGULATION (EU No. 596/2014) AS IT FORMS PART OF UK DOMESTIC LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018. UPON THE PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN AND SUCH PERSONS SHALL THEREFORE CEASE TO BE IN POSSESSION OF INSIDE INFORMATION.
About Agronomics
Agronomics is a leading listed alternative proteins company with a focus on cellular agriculture and cultivated meat. The Company has established a portfolio of 21 companies at the Pre-Seed to Series C stage in this rapidly advancing sector. It seeks to secure minority stakes in companies owning technologies with defensible intellectual property that offer new ways of producing food and materials with a focus on products historically derived from animals. These technologies are driving a major disruption in agriculture, offering solutions to improve sustainability, as well as addressing human health, animal welfare and environmental damage. This disruption will decouple supply chains from the environment and animals, as well as being fundamental to feeding the world's expanding population. A full list of Agronomics' portfolio companies is available at https://agronomics.im/ .
About Cellular Agriculture
Cellular Agriculture is the production of agriculture products directly from cells, as opposed to raising an animal for slaughter, or growing crops. This encompasses cell culture to produce cultivated meat and materials, and fermentation processes that harness a combination of molecular biology, synthetic biology, tissue engineering and biotechnology to massively simplify production methods in a sustainable manner.
Over the coming decades, the source of the world's food supply traditionally derived from conventional agriculture is going to change dramatically. We have already witnessed the first wave of this shift with the consumer adoption of plant-based alternative proteins but today, we are on the cusp of an even bigger wave of change. This is being facilitated by advances in cellular agriculture. This change is necessary, given scientists claims that if we maintain existing animal protein consumption patterns, then we will not meet the Paris Agreement's goal of limiting warming to 1.5
AT Kearney, a global consultancy firm, projects that cultivated meat's market share will reach 35% by 2040. This combined with the Good Food Institute's estimate that a US$ 1.8 trillion investment will be required in order to produce just 10% of the world's protein using this technology, means that we are on the cusp of a multi-decade flow of capital to build out manufacturing facilities. Funding in the field of cellular agriculture is accelerating, however still less than US$ 2 billion has been invested worldwide since the industry's inception in 2016.
Contacts
For further information please contact:
Agronomics Beaumont Canaccord Cenkos Peterhouse TB Cardew Limited Cornish Genuity Limited Securities Capital Limited Plc Limited The Company Nomad Joint Broker Joint Broker Joint Broker Public Relations ---------- ------------------- ------------------ --------------- ------------------------ Richard Reed Roland Andrew Potts Giles Balleny Lucy Williams Ed Orlebar Denham Eke Cornish Harry Rees Max Gould Charles Joe McGregor James Alex Aylen Michael Johnson Goodfellow Biddle (Head of Equities) ---------- ------------------- ------------------ --------------- ------------------------ +44 (0) 20 7930 0777 +44 (0) 1624 +44 (0) +44 (0) +44 (0) 7738 724 639396 207 628 +44 (0) 207 +44 (0) 207 207 469 630 info@agronomics.im 3396 523 8000 397 8900 0936 agronomics@tbcardew.com ---------- ------------------- ------------------ --------------- ------------------------
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
MSCBDLFLLBLEFBK
(END) Dow Jones Newswires
October 27, 2022 07:02 ET (11:02 GMT)
1 Year Agronomics Chart |
1 Month Agronomics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions